Silo Pharma Announces Stock Repurchase Program

ENGLEWOOD CLIFFS, NJ, Jan. 31, 2023 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO)…

INTRODUCING NETRAMARK – A PHARMA AI COMPANY

TORONTO, Jan. 30, 2023 /CNW/ – (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF) -Today we…

Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc.

Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), an industry leader in harnessing…

SANUWAVE Health Commences Trading on the OTCQB Under Ticker Symbol SNWV

SANUWAVE Health, Inc. (OTCQB: SNWV) (“SANUWAVE”), a leading provider of next-generation FDA-approved…

Kraig Biocraft Laboratories Delivers the First Two Hybrid Dragon Silk™ Silkworm Strains for Commercial Production

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology…

Tivic Health Named Most Pioneering Bioelectronic Medicine Company by Global Health & Pharma Magazine

SAN FRANCISCO, January 24, 2023–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a…

Clinical Trial for Recurrent Pericarditis Points to Cardiol Therapeutics’ Potential

When considering investment in a clinical-stage drug development company, it might be…

PsyBio Announces Closing of Second Tranche of Private Placement

Oxford, Ohio and Denver, Colorado–(Newsfile Corp. – January 13, 2023) – PsyBio…

Clearday’s Companion Robotics Robot Mitra Shows Tremendous Acceptance by TRECS Institute which Expanded their Grant Application Program Into 30 States for the 1st qtr. of 2023

San Antonio, Texas, Jan. 11, 2023 (GLOBE NEWSWIRE) — Clearday, Inc. (OTCQX:…

Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation

Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on…